Market overview
The global bioreactor market is worth USD 13.7 bn in 2026 and is forecast to reach USD 35.5 bn by 2036, growing at a 10.0% CAGR. United States is the largest country market and Single-use bioreactors is the largest by type segment.
| Scope | Bioreactors and fermenters for cell culture and microbial processes, including stainless-steel, glass and single-use vessels from laboratory to commercial scale. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 12.5 bn |
| Value 2026 | USD 13.7 bn |
| Value 2036 | USD 35.5 bn |
| CAGR 2026-2036 | 10.0% |
| Volume 2026 | 3,252 thousand units |
| Volume 2036 | 7,637 thousand units |
| Average price 2026 | USD 4,208 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Bioreactor market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 13.7 bn |
| 2027 | USD 15.1 bn |
| 2028 | USD 16.6 bn |
| 2029 | USD 18.2 bn |
| 2030 | USD 20.0 bn |
| 2031 | USD 22.0 bn |
| 2032 | USD 24.2 bn |
| 2033 | USD 26.7 bn |
| 2034 | USD 29.3 bn |
| 2035 | USD 32.3 bn |
| 2036 | USD 35.5 bn |
Bioreactor market segmentation
By type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Single-use bioreactors | 42.0% | 54.1% | USD 5.7 bn | 12.8% |
| Stainless-steel bioreactors | 34.0% | 25.3% | USD 4.7 bn | 6.8% |
| Glass and benchtop bioreactors | 24.0% | 20.6% | USD 3.3 bn | 8.3% |
By cell type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Mammalian cell | 58.0% | 59.9% | USD 7.9 bn | 10.4% |
| Microbial | 24.0% | 20.6% | USD 3.3 bn | 8.4% |
| Insect and others | 18.0% | 19.4% | USD 2.5 bn | 10.8% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Biopharmaceutical companies | 60.0% | 60.1% | USD 8.2 bn | 10.0% |
| Contract manufacturers | 20.0% | 24.0% | USD 2.7 bn | 12.0% |
| Academic and research institutes | 20.0% | 15.9% | USD 2.7 bn | 7.5% |
By scale
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Benchtop and lab | 24.0% | 20.0% | USD 3.3 bn | 8.0% |
| Pilot | 22.0% | 22.0% | USD 3.0 bn | 10.0% |
| Commercial | 54.0% | 58.0% | USD 7.4 bn | 10.8% |
By material
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Stainless steel | 40.0% | 34.0% | USD 5.5 bn | 8.2% |
| Single use | 52.0% | 58.0% | USD 7.1 bn | 11.2% |
| Glass | 8.0% | 8.0% | USD 1.1 bn | 10.0% |
Top 25 countries for bioreactor by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 86.0% of 2026 revenue and the 25 countries below together hold 96.6%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 4.5 bn | 33.0% | USD 11.1 bn | 9.4% |
| 2 | China | USD 1.6 bn | 12.0% | USD 5.5 bn | 12.9% |
| 3 | Germany | USD 1.2 bn | 9.0% | USD 2.8 bn | 8.4% |
| 4 | Switzerland | USD 821 mn | 6.0% | USD 1.9 bn | 8.8% |
| 5 | Japan | USD 684 mn | 5.0% | USD 1.5 bn | 7.8% |
| 6 | South Korea | USD 684 mn | 5.0% | USD 2.0 bn | 11.4% |
| 7 | United Kingdom | USD 684 mn | 5.0% | USD 1.6 bn | 8.8% |
| 8 | India | USD 548 mn | 4.0% | USD 1.8 bn | 12.5% |
| 9 | France | USD 548 mn | 4.0% | USD 1.2 bn | 8.5% |
| 10 | Singapore | USD 411 mn | 3.0% | USD 1.1 bn | 10.4% |
| 11 | Ireland | USD 274 mn | 2.0% | USD 703 mn | 9.9% |
| 12 | Netherlands | USD 242 mn | 1.8% | USD 625 mn | 9.9% |
| 13 | Denmark | USD 183 mn | 1.3% | USD 472 mn | 9.9% |
| 14 | Belgium | USD 138 mn | 1.0% | USD 355 mn | 9.9% |
| 15 | Sweden | USD 114 mn | 0.8% | USD 291 mn | 9.9% |
| 16 | Austria | USD 93 mn | 0.7% | USD 238 mn | 9.8% |
| 17 | Italy | USD 90 mn | 0.7% | USD 231 mn | 9.8% |
| 18 | Spain | USD 79 mn | 0.6% | USD 206 mn | 10.0% |
| 19 | Brazil | USD 56 mn | 0.4% | USD 163 mn | 11.3% |
| 20 | Taiwan | USD 49 mn | 0.4% | USD 142 mn | 11.2% |
| 21 | Israel | USD 37 mn | 0.3% | USD 96 mn | 10.0% |
| 22 | Canada | USD 33 mn | 0.2% | USD 85 mn | 10.0% |
| 23 | Australia | USD 25 mn | 0.2% | USD 64 mn | 10.0% |
| 24 | Poland | USD 22 mn | 0.2% | USD 64 mn | 11.3% |
| 25 | Mexico | USD 19 mn | 0.1% | USD 57 mn | 11.5% |
| Rest of world | USD 461 mn | 3.4% | USD 1.2 bn | 9.8% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Sartorius
- Thermo Fisher Scientific
- Cytiva
- Merck KGaA
- Eppendorf
- Getinge
Group 2: Regional and specialist players
- Pierre Guerin
- Applikon
- Solaris Biotechnology
- Bioengineering AG
- PBS Biotech
- ABEC
- Zeta Group
- Kuhner
- Corning
Group 3: Emerging and niche players
- Distek
- Infors HT
- Cellexus
- Celltainer Biotech
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the bioreactor market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 10.0% is calculated from the resulting values.
The market is divided by type, by cell type, by end user, by scale, by material. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the bioreactor market?
The global bioreactor market is estimated at USD 12.5 bn in 2025 and USD 13.7 bn in 2026.
How fast will the bioreactor market grow?
It is forecast to reach USD 35.5 bn by 2036, a compound annual growth rate of 10.0% from 2026, an increase of USD 21.8 bn.
Which country is the largest market for bioreactor?
United States is the largest market by revenue at USD 4.5 bn in 2026, 33.0% of the global total. The three largest countries together hold 54.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 12.9% a year from 2026 to 2036.
Which bioreactor segment is largest?
In the by type split, Single-use bioreactors is the largest segment with 42.0% of 2026 revenue.
Who are the leading bioreactor companies?
Global leaders include Sartorius, Thermo Fisher Scientific, Cytiva, Merck KGaA.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- RNA TherapeuticsUSD 13.4 bn · 18.0% CAGR
- Implantable Drug DeliveryUSD 12.9 bn · 7.8% CAGR
- ChromatographyUSD 12.6 bn · 6.0% CAGR
- Oligonucleotide TherapeuticsUSD 12.2 bn · 16.0% CAGR
- SpectroscopyUSD 15.4 bn · 6.0% CAGR
- RadiopharmaceuticalsUSD 12.1 bn · 12.5% CAGR
- Pharmaceutical FiltrationUSD 15.8 bn · 9.0% CAGR
- Sterilization EquipmentUSD 11.7 bn · 6.0% CAGR